Bendamustine produces durable responses with an acceptable safety profile in patients with rituximab-refractory indolent non-hodgkin lymphoma

Bruce D. Cheson, Jonathan W. Friedberg, Brad S. Kahl, Richard H. Van Der Jagt, Lothar Tremmel

Research output: Contribution to journal › Article › peer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'Bendamustine produces durable responses with an acceptable safety profile in patients with rituximab-refractory indolent non-hodgkin lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences